CLAYMORE BNY SMCAP LDRS (ARCA: XGC)

View Portfolio
Back to Investopedia
Back to Investopedia




$18.85 0.38 (2.06%)
Turn On
KEY STATS
52-Week High Price
21.76
52-Week Low Price
9.42
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.01 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
0.00
Shares
0.30 M
Dividend Rate ($) / (%)
0.18/0.90
50%
50%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 57% - XGC has outperformed the S&P 500 by 31%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
PWRSHS FTSE RAFI JPN ETF (PJO) $36.81 -  $0.05(0.14%)0.01 B
RYDEX 2X S&P SST ETF (RTG) $45.94 -  $0.60(1.31%)0.01 B
SPDR IND INTL ENERGY ETF (IPW) $24.52 -  $0.50(2.08%)0.01 B
SPDR INTL INDUSTRIAL ETF (IPN) $22.89 -  $0.36(1.61%)0.01 B
WISDOMTREE INTL CON CYCL (DPC) $18.85 -  $0.85(4.72%)0.01 B
CLAYMORE OCEAN TOMO PTNT (OTP) $22.00 -  $0.30(1.36%)0.01 B
CLAYMORE TR 2 ZCK CNTRY (CRO) $15.33 -  $0.73(5.00%)0.01 B
EGA EMERGING GBL ENGY FD (EEO) $42.68 -  $0.84(2.01%)0.01 B
FIRST CAROLINA INVESTORS (FCAR) $6.55 -  $0.00(0.00%)0.01 B
FIRST TR NASDAQ ABA CMTY (QABA) $22.69 -  $0.09(0.40%)0.01 B
As of February 09, 2010 at 4:15 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
XGC RELATED HEADLINES
arrow
Investor Interview With Ward Kadel
Covestor member who works in Biotech talks about his investment focus in the Biotech sector, and the process he applies in screeing journal articles and clinical trials to pick out potential winners
Covestor Member Interviews 2/28/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1